P&G Targets $10 Billion In Cost Savings In Four Years
This article was originally published in The Tan Sheet
P&G targets $10 billion in cost cuts before October 2016, including cutting $4.5 billion in spending on raw and packaging materials for its products and reducing overhead by $3 billion. The firm also plans to cut 5,700 jobs within 18 months.
You may also be interested in...
The marketer of Crest and Prilosec OTC takes a $1.5 billion write-down on its appliances business, and faces continuing pressure from commodity costs. The health care segment’s net sales increased 1% to $3.2 billion, but price increases added 3% to the total, the firm said.
Verona Pharma’s candidate COPD therapy ensifentrine has a first-in-class dual mechanism of action and is to be explored as an add-on to LAMA and LABA therapy in two Phase III clinical studies.
No device-related warning letters were released by the US FDA the week of 2 June.